# Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers

> **NCT03533387** · PHASE1 · COMPLETED · sponsor: **MediciNova** · enrollment: 28 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MN-166

## Key facts

- **NCT ID:** NCT03533387
- **Lead sponsor:** MediciNova
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-11
- **Primary completion:** 2018-07-06
- **Final completion:** 2018-09-30
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03533387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03533387, "Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03533387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*